Ryufin

Redcare Pharmacy N.V.

Netherlands · NL0012044747 · reports in EUR · Europe

The answers

From the annual report for the year to Dec 31, 2025. Each line says what it is based on.

Is it growing?Good
Revenue +24% in the year to Dec 31, 2025, on the year before.
Is it a good business?To watch
It earned −8.2% on its shareholders' equity in the year to Dec 31, 2025.
Is it safe?Fair
Equity is 39% of its assets, and operations brought in cash in the year.
Is the price fair?n/a
Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.

The year

Year to Dec 31, 2025, consolidated, in EUR.

€2.9B

revenue

-0.97%

operating margin

−€38M

net profit

Year by year

As filed; an earlier year can differ from its own report when the company restated it.

Dec 2022Dec 2023Dec 2024Dec 2025
Revenue€1.2B€1.8B€2.4B€2.9B
Operating profit−€69M−€17M−€39M−€29M
Net profit to shareholders−€78M−€12M−€46M−€38M
Earnings per share−€4.32−€0.73−€2.27−€1.87
Cash from operations−€29M€61M€22M€31M
Capital spending€14M€6M€9M€79M
Cash€67M€84M€97M€92M
Total assets€729M€1.0B€1.0B€1.2B
Equity€355M€552M€510M€479M

What they do

In the company's own words, from the annual report.

Redcare Pharmacy N.V. is an online pharmacy business primarily for prescription and non-prescription (“over-the-counter” or “OTC”) pharmaceuticals, beauty and personal care products (BPC) and food supplements

Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.